{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:20:51Z","timestamp":1794608451616,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The coronavirus spike glycoprotein, located on the virion surface, is the key mediator of cell entry and the focus for development of protective antibodies and vaccines. Structural studies show exposed sites on the spike trimer that might be targeted by antibodies with cross-species specificity. Here we isolated two human monoclonal antibodies from immunized humanized mice that display a remarkable cross-reactivity against distinct spike proteins of betacoronaviruses including SARS-CoV, SARS-CoV-2, MERS-CoV and the endemic human coronavirus HCoV-OC43. Both cross-reactive antibodies target the stem helix in the spike S2 fusion subunit which, in the prefusion conformation of trimeric spike, forms a surface exposed membrane-proximal helical bundle. Both antibodies block MERS-CoV infection in cells and provide protection to mice from lethal MERS-CoV challenge in prophylactic and\/or therapeutic models. Our work highlights an immunogenic and vulnerable site on the betacoronavirus spike protein enabling elicitation of antibodies with unusual binding breadth.<\/jats:p>","DOI":"10.1038\/s41467-021-21968-w","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T07:03:23Z","timestamp":1615964603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies"],"prefix":"10.1038","volume":"12","author":[{"given":"Chunyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rien","family":"van Haperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0690-9496","authenticated-orcid":false,"given":"Javier","family":"Guti\u00e9rrez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-762X","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-1079","authenticated-orcid":false,"given":"Nisreen M. A.","family":"Okba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Albulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Widjaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"van Dieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-9010","authenticated-orcid":false,"given":"Raul","family":"Fernandez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-1917","authenticated-orcid":false,"given":"Isabel","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-5808","authenticated-orcid":false,"given":"Daniel L.","family":"Hurdiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan","family":"Daramola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Grosveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5800-749X","authenticated-orcid":false,"given":"Frank J. M.","family":"van Kuppeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-2015","authenticated-orcid":false,"given":"Bart L.","family":"Haagmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9781-1701","authenticated-orcid":false,"given":"Dubravka","family":"Drabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3864-232X","authenticated-orcid":false,"given":"Berend-Jan","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"21968_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"21968_CR2","first-page":"03","volume":"2020","author":"A Gorbalenya","year":"2020","unstructured":"Gorbalenya, A. et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020, 03\u201304 (2020).","journal-title":"Nat. Microbiol."},{"key":"21968_CR3","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/nm1143","volume":"10","author":"J Peiris","year":"2004","unstructured":"Peiris, J., Guan, Y. & Yuen, K. Severe acute respiratory syndrome. Nat. Med. 10, S88\u2013S97 (2004).","journal-title":"Nat. Med."},{"key":"21968_CR4","unstructured":"World Health Organization. MERS situation update, January 2020. http:\/\/www.emro.who.int\/health-topics\/mers-cov\/mersoutbreaks.html (2020)."},{"key":"21968_CR5","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1128\/JCM.00636-10","volume":"48","author":"ER Gaunt","year":"2010","unstructured":"Gaunt, E. R., Hardie, A., Claas, E. C., Simmonds, P. & Templeton, K. E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 48, 2940\u20132947 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"21968_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/diseases4030026","volume":"4","author":"YX Lim","year":"2016","unstructured":"Lim, Y. X., Ng, Y. L., Tam, J. P. & Liu, D. X. Human coronaviruses: a review of virus\u2013host interactions. Diseases 4, 26 (2016).","journal-title":"Diseases"},{"key":"21968_CR7","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/infdis\/jit393","volume":"208","author":"EE Walsh","year":"2013","unstructured":"Walsh, E. E., Shin, J. H. & Falsey, A. R. Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J. Infect. Dis. 208, 1634\u20131642 (2013).","journal-title":"J. Infect. Dis."},{"key":"21968_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMc1509458","volume":"375","author":"S Morfopoulou","year":"2016","unstructured":"Morfopoulou, S. et al. Human coronavirus OC43 associated with fatal encephalitis. N. Engl. J. Med. 375, 497\u2013498 (2016).","journal-title":"N. Engl. J. Med."},{"key":"21968_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su, S. et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24, 490\u2013502 (2016).","journal-title":"Trends Microbiol."},{"key":"21968_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.tim.2013.05.005","volume":"21","author":"JF Chan","year":"2013","unstructured":"Chan, J. F., To, K. K., Tse, H., Jin, D. & Yuen, K. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 21, 544\u2013555 (2013).","journal-title":"Trends Microbiol."},{"key":"21968_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-015-0422-1","volume":"12","author":"B Hu","year":"2015","unstructured":"Hu, B., Ge, X., Wang, L. & Shi, Z. Bat origin of human coronaviruses. Virol. J. 12, 1\u201310 (2015).","journal-title":"Virol. J."},{"key":"21968_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","volume":"27","author":"DR Burton","year":"2020","unstructured":"Burton, D. R. & Walker, L. M. Rational vaccine design in the time of COVID-19. Cell Host Micro. 27, 695\u2013698 (2020).","journal-title":"Cell Host Micro."},{"key":"21968_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1126\/science.1225416","volume":"337","author":"DR Burton","year":"2012","unstructured":"Burton, D. R., Poignard, P., Stanfield, R. L. & Wilson, I. A. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337, 183\u2013186 (2012).","journal-title":"Science"},{"key":"21968_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13764","volume":"516","author":"L Pappas","year":"2014","unstructured":"Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418\u2013422 (2014).","journal-title":"Nature"},{"key":"21968_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417\u2013429.e10 (2018).","journal-title":"Cell"},{"key":"21968_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","volume":"164","author":"AI Flyak","year":"2016","unstructured":"Flyak, A. I. et al. Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection. Cell 164, 392\u2013405 (2016).","journal-title":"Cell"},{"key":"21968_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","volume":"169","author":"AZ Wec","year":"2017","unstructured":"Wec, A. Z. et al. Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses. Cell 169, 878\u2013890.e15 (2017).","journal-title":"Cell"},{"key":"21968_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","volume":"49","author":"P Gilchuk","year":"2018","unstructured":"Gilchuk, P. et al. Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein. Immunity 49, 363\u2013374 (2018). e10.","journal-title":"Immunity"},{"key":"21968_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinf.2013.03.015","volume":"67","author":"K Chan","year":"2013","unstructured":"Chan, K. et al. Cross-reactive antibodies in convalescent SARS patients\u2019 sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 67, 130\u2013140 (2013).","journal-title":"J. Infect."},{"key":"21968_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"184","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 184, 828\u2013842 (2020).","journal-title":"Cell"},{"key":"21968_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.abc7424","volume":"369","author":"AZ Wec","year":"2020","unstructured":"Wec, A. Z. et al. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science 369, 731\u2013736 (2020).","journal-title":"Science"},{"key":"21968_CR22","first-page":"1","volume":"8","author":"RN Kirchdoerfer","year":"2018","unstructured":"Kirchdoerfer, R. N. et al. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"21968_CR23","doi-asserted-by":"publisher","first-page":"e51230","DOI":"10.7554\/eLife.51230","volume":"8","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. The human coronavirus HCoV-229E S-protein structure and receptor binding. Elife 8, e51230 (2019).","journal-title":"Elife"},{"key":"21968_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","volume":"26","author":"Y Park","year":"2019","unstructured":"Park, Y. et al. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 26, 1151\u20131157 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"21968_CR25","doi-asserted-by":"publisher","first-page":"e1007009","DOI":"10.1371\/journal.ppat.1007009","volume":"14","author":"J Shang","year":"2018","unstructured":"Shang, J. et al. Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins. PLoS Pathog. 14, e1007009 (2018).","journal-title":"PLoS Pathog."},{"key":"21968_CR26","doi-asserted-by":"publisher","unstructured":"Shang, J. et al. Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01556-17 (2018).","DOI":"10.1128\/JVI.01556-17"},{"key":"21968_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481\u2013489 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"21968_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature16988","volume":"531","author":"AC Walls","year":"2016","unstructured":"Walls, A. C. et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531, 114\u2013117 (2016).","journal-title":"Nature"},{"key":"21968_CR29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039.e15 (2019).","journal-title":"Cell"},{"key":"21968_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms15092","volume":"8","author":"Y Yuan","year":"2017","unstructured":"Yuan, Y. et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 8, 1\u20139 (2017).","journal-title":"Nat. Commun."},{"key":"21968_CR31","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abd4251","volume":"369","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Distinct conformational states of SARS-CoV-2 spike protein. Science 369, 1586\u20131592 (2020).","journal-title":"Science"},{"key":"21968_CR32","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"21968_CR33","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/nm.3985","volume":"21","author":"VD Menachery","year":"2015","unstructured":"Menachery, V. D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med. 21, 1508\u20131513 (2015).","journal-title":"Nat. Med."},{"key":"21968_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat. Commun. 11, 1\u20136 (2020).","journal-title":"Nat. Commun."},{"key":"21968_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41594-020-0480-y","volume":"27","author":"D Zhou","year":"2020","unstructured":"Zhou, D. et al. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat. Struct. Mol. Biol. 27, 950\u2013958 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"21968_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"369","author":"P Brouwer","year":"2020","unstructured":"Brouwer, P. et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 369, 643\u2013650 (2020).","journal-title":"Science"},{"key":"21968_CR37","doi-asserted-by":"publisher","first-page":"107725","DOI":"10.1016\/j.celrep.2020.107725","volume":"31","author":"H Lv","year":"2020","unstructured":"Lv, H. et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. 31, 107725 (2020).","journal-title":"Cell Rep."},{"key":"21968_CR38","doi-asserted-by":"crossref","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","DOI":"10.1038\/s41586-020-2349-y"},{"key":"21968_CR39","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1126\/science.abc5881","volume":"369","author":"Z Lv","year":"2020","unstructured":"Lv, Z. et al. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science 369, 1505\u20131509 (2020).","journal-title":"Science"},{"key":"21968_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956\u2013963 (2020).","journal-title":"Science"},{"key":"21968_CR41","doi-asserted-by":"publisher","unstructured":"Haagmans, B. L. et al. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model. Preprint at https:\/\/doi.org\/10.1101\/2020.08.24.264630 (2020).","DOI":"10.1101\/2020.08.24.264630"},{"key":"21968_CR42","doi-asserted-by":"crossref","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6 (2020).","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"21968_CR43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/22221751.2019.1597644","volume":"8","author":"I Widjaja","year":"2019","unstructured":"Widjaja, I. et al. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg. Microb. Infect. 8, 516\u2013530 (2019).","journal-title":"Emerg. Microb. Infect."},{"key":"21968_CR44","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt, F. et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp. Med. 217, e20201181 (2020).","journal-title":"J. Exp. Med."},{"key":"21968_CR45","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.celrep.2017.08.084","volume":"20","author":"S Lang","year":"2017","unstructured":"Lang, S. et al. Antibody 27F3 broadly targets influenza A group 1 and 2 hemagglutinins through a further variation in VH1-69 antibody orientation on the HA stem. Cell Rep. 20, 2935\u20132943 (2017).","journal-title":"Cell Rep."},{"key":"21968_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","volume":"34","author":"F Chen","year":"2019","unstructured":"Chen, F., Tzarum, N., Wilson, I. A. & Law, M. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. Curr. Opin. Virol. 34, 149\u2013159 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"21968_CR47","doi-asserted-by":"publisher","first-page":"e1004103","DOI":"10.1371\/journal.ppat.1004103","volume":"10","author":"Y Avnir","year":"2014","unstructured":"Avnir, Y. et al. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS Pathog. 10, e1004103 (2014).","journal-title":"PLoS Pathog."},{"key":"21968_CR48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","volume":"46","author":"MK Gorny","year":"2009","unstructured":"Gorny, M. K. et al. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol. Immunol. 46, 917\u2013926 (2009).","journal-title":"Mol. Immunol."},{"key":"21968_CR49","doi-asserted-by":"publisher","first-page":"aab1253","DOI":"10.1126\/science.aab1253","volume":"349","author":"WB Williams","year":"2015","unstructured":"Williams, W. B. et al. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science 349, aab1253 (2015).","journal-title":"Science"},{"key":"21968_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","volume":"166","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609\u2013623 (2016).","journal-title":"Cell"},{"key":"21968_CR51","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nsmb.3293","volume":"23","author":"AC Walls","year":"2016","unstructured":"Walls, A. C. et al. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 23, 899 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"21968_CR52","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.1073\/pnas.1708727114","volume":"114","author":"AC Walls","year":"2017","unstructured":"Walls, A. C. et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl Acad. Sci. USA 114, 11157\u201311162 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21968_CR53","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/jiv499","volume":"213","author":"K Li","year":"2016","unstructured":"Li, K. et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J. Infect. Dis. 213, 712\u2013722 (2016).","journal-title":"J. Infect. Dis."},{"key":"21968_CR54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"21968_CR55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","volume":"161","author":"AG Schmidt","year":"2015","unstructured":"Schmidt, A. G. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026\u20131034 (2015).","journal-title":"Cell"},{"key":"21968_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1128\/jvi.65.1.254-262.1991","volume":"65","author":"E Routledge","year":"1991","unstructured":"Routledge, E., Stauber, R., Pfleiderer, M. & Siddell, S. G. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J. Virol. 65, 254\u2013262 (1991).","journal-title":"J. Virol."},{"key":"21968_CR57","doi-asserted-by":"publisher","first-page":"e50366","DOI":"10.1371\/journal.pone.0050366","volume":"7","author":"HA Elshabrawy","year":"2012","unstructured":"Elshabrawy, H. A., Coughlin, M. M., Baker, S. C. & Prabhakar, B. S. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS ONE 7, e50366 (2012).","journal-title":"PLoS ONE"},{"key":"21968_CR58","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","volume":"80","author":"KM Lip","year":"2006","unstructured":"Lip, K. M. et al. Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus. J. Virol. 80, 941\u2013950 (2006).","journal-title":"J. Virol."},{"key":"21968_CR59","doi-asserted-by":"publisher","first-page":"17958","DOI":"10.1073\/pnas.0406128102","volume":"101","author":"VM Supekar","year":"2004","unstructured":"Supekar, V. M. et al. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proc. Natl Acad. Sci. USA 101, 17958\u201317963 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21968_CR60","doi-asserted-by":"publisher","first-page":"30514","DOI":"10.1074\/jbc.M403760200","volume":"279","author":"Y Xu","year":"2004","unstructured":"Xu, Y. et al. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J. Biol. Chem. 279, 30514\u201330522 (2004).","journal-title":"J. Biol. Chem."},{"key":"21968_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09732-7","volume":"10","author":"LB King","year":"2019","unstructured":"King, L. B. et al. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nat. Commun. 10, 1\u20138 (2019).","journal-title":"Nat. Commun."},{"key":"21968_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0014-5793(99)00458-5","volume":"450","author":"C Berger","year":"1999","unstructured":"Berger, C. et al. Antigen recognition by conformational selection. FEBS Lett. 450, 149\u2013153 (1999).","journal-title":"FEBS Lett."},{"key":"21968_CR63","doi-asserted-by":"publisher","unstructured":"Rappazzo, C. G. et al. An engineered antibody with broad protective efficacy in murine models of SARS and COVID-19. Preprint at https:\/\/doi.org\/10.1101\/2020.11.17.385500 (2020).","DOI":"10.1101\/2020.11.17.385500"},{"key":"21968_CR64","doi-asserted-by":"crossref","unstructured":"Song, G. et al. Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Preprint at https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7523096\/(2020).","DOI":"10.1101\/2020.09.22.308965"},{"key":"21968_CR65","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41423-020-00523-5","volume":"17","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell Mol. Immunol. 17, 1095\u20131097 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"21968_CR66","doi-asserted-by":"publisher","first-page":"100189","DOI":"10.1016\/j.xcrm.2020.100189","volume":"2","author":"JT Ladner","year":"2021","unstructured":"Ladner, J. T. et al. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. Cell Rep. Med. 2, 100189 (2021).","journal-title":"Cell Rep. Med."},{"key":"21968_CR67","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","volume":"24","author":"K Xu","year":"2018","unstructured":"Xu, K. et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. 24, 857\u2013867 (2018).","journal-title":"Nat. Med."},{"key":"21968_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","volume":"23","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. & Krammer, F. Universal influenza virus vaccines and therapeutic antibodies. Clin. Microbiol. Infec. 23, 222\u2013228 (2017).","journal-title":"Clin. Microbiol. Infec."},{"key":"21968_CR69","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chom.2017.07.013","volume":"22","author":"JE Crowe Jr","year":"2017","unstructured":"Crowe, J. E. Jr Principles of broad and potent antiviral human antibodies: insights for vaccine design. Cell Host Micro. 22, 193\u2013206 (2017).","journal-title":"Cell Host Micro."},{"key":"21968_CR70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/btpr.1809","volume":"30","author":"O Daramola","year":"2014","unstructured":"Daramola, O. et al. A high\u2010yielding CHO transient system: coexpression of genes encoding EBNA\u20101 and GS enhances transient protein expression. Biotechnol. Prog. 30, 132\u2013141 (2014).","journal-title":"Biotechnol. Prog."},{"key":"21968_CR71","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1128\/jvi.69.4.2633-2636.1995","volume":"69","author":"TA Gahn","year":"1995","unstructured":"Gahn, T. A. & Sugden, B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69, 2633\u20132636 (1995).","journal-title":"J. Virol."},{"key":"21968_CR72","doi-asserted-by":"crossref","unstructured":"Liu, H. F., Ma, J., Winter, C. & Bayer, R. Recovery and Purification Process Development for Monoclonal Antibody Production (MAbs Ser. 2, Taylor & Francis, 2010).","DOI":"10.4161\/mabs.2.5.12645"},{"key":"21968_CR73","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1073\/pnas.1809667116","volume":"116","author":"RJG Hulswit","year":"2019","unstructured":"Hulswit, R. J. G. et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl Acad. Sci. USA 116, 2681\u20132690 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21968_CR74","doi-asserted-by":"publisher","first-page":"eaas9667","DOI":"10.1126\/sciadv.aas9667","volume":"4","author":"VS Raj","year":"2018","unstructured":"Raj, V. S. et al. Chimeric camel\/human heavy-chain antibodies protect against MERS-CoV infection. Sci. Adv. 4, eaas9667 (2018).","journal-title":"Sci. Adv."},{"key":"21968_CR75","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"NM Okba","year":"2020","unstructured":"Okba, N. M. et al. Severe acute respiratory syndrome coronavirus 2\u2212 specific antibody responses in coronavirus disease patients. Emerg. Infect. Dis. 26, 1478\u20131488 (2020).","journal-title":"Emerg. Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21968-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T18:04:49Z","timestamp":1675015489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21968-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["21968"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-21968-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.W., R.v.H., W.L., I.W., B.v.D., N.M.A.O., F.G., F.J.M.v.K., B.L.H., D.D., and B.J.B. are inventors on a patent application on monoclonal antibodies targeting MERS-CoV (patent publication no.: WO\/2020\/169755). F.G., D.D. and R.H. are non-substantial interest shareholders in Harbour Biomed and were part of the team that generated the mice. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1715"}}